222 related articles for article (PubMed ID: 34900141)
1. M-MuLV reverse transcriptase: Selected properties and improved mutants.
Oscorbin IP; Filipenko ML
Comput Struct Biotechnol J; 2021; 19():6315-6327. PubMed ID: 34900141
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Reverse Transcriptase (RT) Activities of Various M-MuLV RTs for RT-LAMP Assays.
Oscorbin IP; Novikova LM; Filipenko ML
Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552320
[TBL] [Abstract][Full Text] [Related]
3. The attachment of a DNA-binding Sso7d-like protein improves processivity and resistance to inhibitors of M-MuLV reverse transcriptase.
Oscorbin IP; Wong PF; Boyarskikh UA; Khrapov EA; Filipenko ML
FEBS Lett; 2020 Dec; 594(24):4338-4356. PubMed ID: 32970841
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic differences in RNA-dependent DNA polymerization and fidelity between murine leukemia virus and HIV-1 reverse transcriptases.
Skasko M; Weiss KK; Reynolds HM; Jamburuthugoda V; Lee K; Kim B
J Biol Chem; 2005 Apr; 280(13):12190-200. PubMed ID: 15644314
[TBL] [Abstract][Full Text] [Related]
5. Lysine 152 of MuLV reverse transcriptase is required for the integrity of the active site.
Shi Q; Singh K; Srivastava A; Kaushik N; Modak MJ
Biochemistry; 2002 Dec; 41(50):14831-42. PubMed ID: 12475231
[TBL] [Abstract][Full Text] [Related]
6. RNase H cleavage of tRNAPro mediated by M-MuLV and HIV-1 reverse transcriptases.
Smith CM; Potts WB; Smith JS; Roth MJ
Virology; 1997 Mar; 229(2):437-46. PubMed ID: 9126256
[TBL] [Abstract][Full Text] [Related]
7. RNase H domain mutations affect the interaction between Moloney murine leukemia virus reverse transcriptase and its primer-template.
Telesnitsky A; Goff SP
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1276-80. PubMed ID: 7679498
[TBL] [Abstract][Full Text] [Related]
8. A Novel Thermostable and Processive Reverse Transcriptase from a Group II Intron of
Oscorbin IP; Filipenko ML
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254649
[TBL] [Abstract][Full Text] [Related]
9. Valine of the YVDD motif of moloney murine leukemia virus reverse transcriptase: role in the fidelity of DNA synthesis.
Kaushik N; Chowdhury K; Pandey VN; Modak MJ
Biochemistry; 2000 May; 39(17):5155-65. PubMed ID: 10819983
[TBL] [Abstract][Full Text] [Related]
10. Generation and characterization of new highly thermostable and processive M-MuLV reverse transcriptase variants.
Baranauskas A; Paliksa S; Alzbutas G; Vaitkevicius M; Lubiene J; Letukiene V; Burinskas S; Sasnauskas G; Skirgaila R
Protein Eng Des Sel; 2012 Oct; 25(10):657-68. PubMed ID: 22691702
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine 222, a member of the YXDD motif of MuLV RT, is catalytically essential and is a major component of the fidelity center.
Kaushik N; Singh K; Alluru I; Modak MJ
Biochemistry; 1999 Mar; 38(9):2617-27. PubMed ID: 10052931
[TBL] [Abstract][Full Text] [Related]
12. Multiple nucleotide preferences determine cleavage-site recognition by the HIV-1 and M-MuLV RNases H.
Schultz SJ; Zhang M; Champoux JJ
J Mol Biol; 2010 Mar; 397(1):161-78. PubMed ID: 20122939
[TBL] [Abstract][Full Text] [Related]
13. Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H.
Verma IM
J Virol; 1975 Apr; 15(4):843-54. PubMed ID: 46925
[TBL] [Abstract][Full Text] [Related]
14. A colorimetric reverse transcriptase assay optimized for Moloney murine leukemia virus, and its use for characterization of reverse transcriptases of unknown identity.
Malmsten A; Ekstrand DH; Akerblom L; Gronowitz JS; Källander CF; Bendinelli M; Matteucci D
J Virol Methods; 1998 Nov; 75(1):9-20. PubMed ID: 9820570
[TBL] [Abstract][Full Text] [Related]
15. Nuclease activities of Moloney murine leukemia virus reverse transcriptase. Mutants with altered substrate specificities.
Blain SW; Goff SP
J Biol Chem; 1993 Nov; 268(31):23585-92. PubMed ID: 7693692
[TBL] [Abstract][Full Text] [Related]
16. Physiological magnesium concentrations increase fidelity of diverse reverse transcriptases from HIV-1, HIV-2, and foamy virus, but not MuLV or AMV.
Wang R; Belew AT; Achuthan V; El Sayed N; DeStefano JJ
J Gen Virol; 2021 Dec; 102(12):. PubMed ID: 34904939
[TBL] [Abstract][Full Text] [Related]
17. Role of Q190 of MuLV RT in ddNTP resistance and fidelity of DNA synthesis: a molecular model of interactions with substrates.
Singh K; Kaushik N; Jin J; Madhusudanan M; Modak MJ
Protein Eng; 2000 Sep; 13(9):635-43. PubMed ID: 11054458
[TBL] [Abstract][Full Text] [Related]
18. Insertion of a peptide from MuLV RT into the connection subdomain of HIV-1 RT results in a functionally active chimeric enzyme in monomeric conformation.
Pandey PK; Kaushik N; Talele TT; Yadav PN; Pandey VN
Mol Cell Biochem; 2001 Sep; 225(1-):135-44. PubMed ID: 11716355
[TBL] [Abstract][Full Text] [Related]
19. Influence of the RNase H domain of retroviral reverse transcriptases on the metal specificity and substrate selection of their polymerase domains.
Talele TT; Upadhyay A; Pandey VN
Virol J; 2009 Oct; 6():159. PubMed ID: 19814799
[TBL] [Abstract][Full Text] [Related]
20. Relationship between plus strand DNA synthesis removal of downstream segments of RNA by human immunodeficiency virus, murine leukemia virus and avian myeloblastoma virus reverse transcriptases.
Fuentes GM; Fay PJ; Bambara RA
Nucleic Acids Res; 1996 May; 24(9):1719-26. PubMed ID: 8649991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
